Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia
Xin Huang(BGI Group (China)), Jun J. Yang(St. Jude Children's Research Hospital)
Cited by 31
Related Papers
Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse
|Nature Genetics|2013|308
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
|Nature Genetics|2013|293
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study
|The Lancet Oncology|2015|210
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma
|Nature Communications|2023|41